Machine Learning Researcher at PostEra
About the role
PostEra is building a one-stop-shop for medicinal chemistry to serve the world's drug hunters.
This role will be focused on developing machine learning algorithms to design molecular structures, forecast chemical properties and predict the outcomes of organic synthesis -- a problem akin to that of games like Go and Chess but with huge therapeutic implications for patients around the world!
The candidate will work with an expert team in the area of machine learning for drug discovery, and support ongoing projects with pharma and biotech clients in their drug discovery efforts, as well as developing new machine learning techniques. We envisage that some of the work will be showcased at top conferences/journals -- giving back to the scientific community is a core value of PostEra as evidenced by our recent project leading the COVID Moonshot initiative: https://postera.ai/covid
Why you should join PostEra
What do we do?
PostEra offers medicinal chemistry as a service. Drug discovery R&D is slow and expensive and this limits biotechs and pharma from getting new drugs into development and new cures to patients. PostEra is building a one-stop-shop for medicinal chemistry, powered by machine learning, to serve the world's ever expanding community of drug hunters while also leading the world's largest open-science initiative to find a COVID cure; COVID Moonshot.
What are we working on?
The answer is many things but here's our top priorities right now:
Partnerships: We partner with drug hunters and help them get cures to patients faster. We're currently collaborating with Pfizer and several small biotechs, using all of PostEra's ML to help their drug discovery.
We are building Manifold; the first-of-its-kind cloud platform for scientists to design and order molecules.
COVID Moonshot: PostEra is helping lead the world's largest open-source drug discovery effort. Moonshot is an international team of scientists working on an antiviral cure for COVID. Our platform for crowd-sourcing drug designs has received over 15,000 submissions and we're now moving to in vivo testing of the most promising of these compounds.
How are we funded?
PostEra has raised over $2.5m since inception from leading Angel investors as well as several Bay Area VCs.